Search

In 2024, the MSK Giving community raised $511 million to advance MSK’s mission of ending cancer for life — every single dollar donated is making a real difference in the way we treat and understand cancer.

… Friday, June 6, 2025 In 2024, we invited the MSK Giving community to join an ambitious effort to raise $6 billion by 2030 and shape the future of cancer care — The MSK Campaign: Leading Science. Changing Lives .  In response, MSK donors contributed $511 million to advance MSK’s mission of ending cancer

Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.

… Friday, July 1, 2011 Summary Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions. When chromosomes are copied and divided faithfully and no DNA damage is passed on, a parent cell gives rise to two identical

Mitochondria provide both the energy cells need to survive and the building blocks they need to grow and divide. Researchers at the Sloan Kettering Institute reveal for the first time how mitochondria choose between these opposing paths — and what implications it may have for cancer.

… Wednesday, November 6, 2024 Many of us remember from high school biology class that mitochondria are the cell’s “power plants.” These small kidney-bean-shaped structures are what convert nutrients from food into ATP — the cell’s “energy currency.” Cells spend that currency every time they perform basic

… Friday, May 30, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Andrea Cercek and Vinod Balachandran Named to the 2025 TIME100 Health List Andrea Cercek and Vinod Balachandran Named to the 2025 TIME100 Health List Andrea Cercek, MD , gastrointestinal

A high-dose radiation treatment is effective for pancreatic cancer patients who cannot have surgery.

… Thursday, March 11, 2021 Summary Pancreatic cancer is notoriously difficult to treat, partly because surgery is not possible or is ineffective. MSK has developed a high-dose form of radiation therapy that can give safe, effective treatment to many patients who are unable to have surgery. Pancreatic cancer

Science could lead to a new type of opioid drug that blocks pain but has a lower potential for addiction or abuse.

… Thursday, January 4, 2018 Summary A multicenter team of researchers is using structural and chemical biology to determine ways to block pain with opioids that have a lower potential for addiction or abuse. The United States is in the midst of an opioid epidemic. According to the Centers for Disease Control

Follow these guidelines for holding difficult yet important end-of-life conversations.

… Thursday, June 20, 2019 Summary End-of-life conversations are never easy. Your care team at Memorial Sloan Kettering is here to listen to your wishes and validate your feelings. Not many people are comfortable talking about death. But sometimes, the only way to get more comfortable with something is

Each summer, four summer students are named Rubin and Sarah Shaps Scholars. They are selected on the basis of their outstanding undergraduate credentials and their performance in our Summer Undergraduate Research Program.

… Tuesday, August 30, 2011 Each summer, four summer students are named Rubin and Sarah Shaps Scholars. They are selected on the basis of their outstanding undergraduate credentials and their performance in our Summer Undergraduate Research Program. Daniel Holohan, a sophomore majoring in Biochemistry/Molecular

Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.

… Tuesday, October 25, 2022 People with multiple myeloma , a rare blood cancer, got good news today when the FDA approved a new drug for resistant forms of the disease. The drug, teclistamab, has been proven effective in treating people with multiple myeloma for whom previous therapies have not worked.

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.

… Thursday, December 21, 2023 Summary Treatment for high-risk forms of neuroblastoma is effective but can cause serious complications. MSK researchers are investigating using a lower radiation dose to treat this cancer, which occurs in young children. Early results have shown that a reduced radiation dose